image
Healthcare - Biotechnology - NASDAQ - US
$ 4.01
-2.67 %
$ 171 M
Market Cap
-7.86
P/E
BALANCE SHEET
54.2 M ASSETS
57.46%
3.1 M LIABILITIES
20.83%
51.1 M EQUITY
60.42%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition DiaMedica Therapeutics Inc.
image
Current Assets 53.7 M
Cash & Short-Term Investments 52.9 M
Receivables 369 K
Other Current Assets 411 K
Non-Current Assets 485 K
Long-Term Investments 0
PP&E 485 K
Other Non-Current Assets 0
Current Liabilities 2.79 M
Accounts Payable 926 K
Short-Term Debt 166 K
Other Current Liabilities 1.69 M
Non-Current Liabilities 317 K
Long-Term Debt 634 K
Other Non-Current Liabilities -317 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004
ASSETS
Cash & Cash Equivalents 4.5 4.7 4.7 7.4 3.9 16.8 1.4 1.7 0.2 0.2 2.5 2.3 2.7 2.8 0.6 2.5 3.5 0.3 0.3 7.64 K
Short Term Investments 48.4 28.8 40.4 20.1 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.4 82 K 0.1 0.3 0.8 0.8 80 K 52 K 9.62 K 8.41 K 0 0 50.4 K 0.2 47.9 K 31.1 K 95.5 K 57.1 K 30.2 K 20 K
Inventory 0 0 0.1 10 K 88 K 0 0 0 1.24 0.000001 1 0 1 1 1 1 1 0.678 2 0
Other Current Assets 0.4 0.3 0.2 74 K 0.1 0.4 61 K 65.2 K 32.9 K 53.9 K 81.7 K 0.1 33.7 K 83.8 K 17.2 K 42 K 50.1 K 9.88 K 13.5 K 0
Total Current Assets 53.7 33.8 45.4 27.9 8.8 18.0 1.5 1.9 0.2 0.3 2.6 2.5 2.7 3.1 0.7 2.5 3.6 0.3 0.3 27.6 K
PP&E 0.5 0.6 0.1 0.2 0.2 96 K 37 K 19.4 K 14.3 K 15.6 K 19.7 K 6.59 K 7.48 K 8.89 K 87.9 K 99.8 K 0.2 13.1 K 16.1 K 19.5 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0.3 1.4 0 5.9 0.5 0.4 0.5 0.4 0.2 0.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0.3 0.3 0 0 0 1 0.0915 0.0784 0.422 0 1 0 1 1 0
Other Assets 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 0 0 0 1
Total Assets 54.2 34.4 45.6 28.1 9.1 18.3 1.8 1.9 0.2 0.3 2.9 3.8 6.3 9.1 1.2 3.0 4.3 0.7 0.6 0.2
LIABILITIES
Accounts Payable 0.9 0.7 0.5 1.1 0.2 0.5 0.5 0.2 0.7 1.0 0.4 1.1 0.1 0 0 0 0.3 53.3 K 56.5 K 0.7
Short Term Debt 0.2 0.1 98 K 0.1 0.1 5 K 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0.2
Other Current Liabilities 1.7 1.3 0.9 0.8 1.0 0.8 0.5 0.4 95.1 K 0.9 1.2 0.4 0.2 0.6 0.2 0.2 0 0 0 0.4
Total Current Liabilities 2.8 2.2 1.5 2.0 1.3 1.3 1.0 0.6 1.1 1.8 1.5 1.6 0.4 0.6 0.2 0.2 0.3 53.3 K 56.5 K 1.3
Long Term Debt 0.6 0.8 6 K 0.1 0.2 36 K 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities (0.3) (0.4) 3 K 53 K (0.1) 18 K 0 0 1.04 K 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 3.1 2.6 1.5 2.1 1.4 1.3 1.0 0.6 1.5 1.8 1.5 1.6 0.4 0.6 0.2 0.2 0.3 53.3 K 56.5 K 1.3
EQUITY
Common Stock 0 0 0 0 0 0 0 41.0 28.1 32.3 K 33.6 K 30.2 K 0 0 0 0 0 0 0 0
Retained Earnings (115.6) (96.2) (82.5) (68.9) (56.6) (46.0) (40.2) (46.7) (34.0) (38.9) (37.1) (31.8) (21.2) (14.9) (10.2) (6.6) (5.9) (3.0) (2.2) (2.0)
Other Accumulative Comprehensive Income/Loss 6 K 74 K 51 K 2 K 2 K 24 K 0.6 0.6 20.9 K 20.1 K 19.2 K 15.8 K 10.7 K 8.02 K 95 K 57.4 K 91.4 K 23.1 K 20.2 K 13.6 K
Total Equity 51.1 31.8 44.0 26.0 7.6 17.0 0.8 1.2 (1.2) (1.5) 1.4 2.3 6.0 8.5 1.0 2.8 4.1 0.7 0.5 (1.1)
Total Liabilities and Equity 54.2 34.4 45.6 28.1 9.1 18.3 1.8 1.9 0.2 0.3 2.9 3.8 6.3 9.1 1.2 3.0 4.3 0.7 0.6 0.2
SHARES OUTSTANDING
Common Shares Outstanding 32.6 26.4 20.8 15.7 12.0 7.7 5.9 4.7 3.6 3.1 2.7 2.4 2.3 1.4 1.0 0.9 0.8 0.9 0.4 0.3